These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 25096718)
1. Identification of a novel AMPK-PEA15 axis in the anoikis-resistant growth of mammary cells. Hindupur SK; Balaji SA; Saxena M; Pandey S; Sravan GS; Heda N; Kumar MV; Mukherjee G; Dey D; Rangarajan A Breast Cancer Res; 2014 Aug; 16(4):420. PubMed ID: 25096718 [TBL] [Abstract][Full Text] [Related]
2. The protein phosphatase 4 - PEA15 axis regulates the survival of breast cancer cells. Mohammed HN; Pickard MR; Mourtada-Maarabouni M Cell Signal; 2016 Sep; 28(9):1389-1400. PubMed ID: 27317964 [TBL] [Abstract][Full Text] [Related]
3. Loss of anchorage primarily induces non-apoptotic cell death in a human mammary epithelial cell line under atypical focal adhesion kinase signaling. Ishikawa F; Ushida K; Mori K; Shibanuma M Cell Death Dis; 2015 Jan; 6(1):e1619. PubMed ID: 25611393 [TBL] [Abstract][Full Text] [Related]
4. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia suppression of Bim and Bmf blocks anoikis and luminal clearing during mammary morphogenesis. Whelan KA; Caldwell SA; Shahriari KS; Jackson SR; Franchetti LD; Johannes GJ; Reginato MJ Mol Biol Cell; 2010 Nov; 21(22):3829-37. PubMed ID: 20861305 [TBL] [Abstract][Full Text] [Related]
6. Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression. Park J; Tacam MJ; Chauhan G; Cohen EN; Gagliardi M; Iles LR; Ueno NT; Battula VL; Sohn YK; Wang X; Kim HS; Krishnamurthy S; Fowlkes NW; Green MM; Bartholomeusz GA; Tripathy D; Reuben JM; Bartholomeusz C Breast Cancer Res Treat; 2021 Sep; 189(2):333-345. PubMed ID: 34241740 [TBL] [Abstract][Full Text] [Related]
7. PEA‑15 contributes to the clinicopathology and AKT‑regulated cisplatin resistance in gastric cancer. Jiang X; Zhang C; Li W; Jiang D; Wei Z; Lv M; Xie X; Sun X Oncol Rep; 2019 Mar; 41(3):1949-1959. PubMed ID: 30569123 [TBL] [Abstract][Full Text] [Related]
8. ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth. Khan IA; Yoo BH; McPhee M; Masson O; Surette A; Dakin-Hache K; Younis T; Bethune G; Rosen KV Breast Cancer Res; 2018 Dec; 20(1):151. PubMed ID: 30545388 [TBL] [Abstract][Full Text] [Related]
9. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells. Haenssen KK; Caldwell SA; Shahriari KS; Jackson SR; Whelan KA; Klein-Szanto AJ; Reginato MJ J Cell Sci; 2010 Apr; 123(Pt 8):1373-82. PubMed ID: 20332114 [TBL] [Abstract][Full Text] [Related]
10. Blockade of CCN6 (WISP3) activates growth factor-independent survival and resistance to anoikis in human mammary epithelial cells. Huang W; Gonzalez ME; Toy KA; Banerjee M; Kleer CG Cancer Res; 2010 Apr; 70(8):3340-50. PubMed ID: 20395207 [TBL] [Abstract][Full Text] [Related]
11. Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. Vitolo MI; Weiss MB; Szmacinski M; Tahir K; Waldman T; Park BH; Martin SS; Weber DJ; Bachman KE Cancer Res; 2009 Nov; 69(21):8275-83. PubMed ID: 19843859 [TBL] [Abstract][Full Text] [Related]
12. TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation. Oberst MD; Beberman SJ; Zhao L; Yin JJ; Ward Y; Kelly K BMC Cancer; 2008 Jul; 8():189. PubMed ID: 18597688 [TBL] [Abstract][Full Text] [Related]
13. PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway. Tang B; Liang W; Liao Y; Li Z; Wang Y; Yan C Oncol Rep; 2019 Jan; 41(1):43-56. PubMed ID: 30365128 [TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15. Bartholomeusz C; Itamochi H; Nitta M; Saya H; Ginsberg MH; Ueno NT Oncogene; 2006 Jan; 25(1):79-90. PubMed ID: 16170361 [TBL] [Abstract][Full Text] [Related]
15. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells. Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795 [TBL] [Abstract][Full Text] [Related]